Published in Neuropharmacology on July 23, 2010
Calpain 2 activated through N-methyl-D-aspartic acid receptor signaling cleaves CPEB3 and abrogates CPEB3-repressed translation in neurons. Mol Cell Biol (2012) 0.95
Calcium channel blockers and dementia. Br J Pharmacol (2013) 0.91
Calpain dysregulation in Alzheimer's disease. ISRN Biochem (2012) 0.79
Temporal dependence of cysteine protease activation following excitotoxic hippocampal injury. Neuroscience (2012) 0.79
Essential protective role of tumor necrosis factor receptor 2 in neurodegeneration. Proc Natl Acad Sci U S A (2016) 0.78
Neuroprotective strategies against calpain-mediated neurodegeneration. Neuropsychiatr Dis Treat (2015) 0.76
Immunization with Small Amyloid-β-derived Cyclopeptide Conjugates Diminishes Amyloid-β-Induced Neurodegeneration in Mice. J Alzheimers Dis (2016) 0.75
Amyloid beta: structure, biology and structure-based therapeutic development. Acta Pharmacol Sin (2017) 0.75
Globular amyloid beta-peptide oligomer - a homogenous and stable neuropathological protein in Alzheimer's disease. J Neurochem (2005) 3.06
Permanent, bilateral common carotid artery occlusion in the rat: a model for chronic cerebral hypoperfusion-related neurodegenerative diseases. Brain Res Rev (2007) 2.17
Cellular and network mechanisms underlying spontaneous sharp wave-ripple complexes in mouse hippocampal slices. J Physiol (2003) 1.76
Neotendon formation induced by manipulation of the Smad8 signalling pathway in mesenchymal stem cells. J Clin Invest (2006) 1.69
Amyloid beta oligomers (A beta(1-42) globulomer) suppress spontaneous synaptic activity by inhibition of P/Q-type calcium currents. J Neurosci (2008) 1.54
Tendon and ligament engineering in the adult organism: mesenchymal stem cells and gene-therapeutic approaches. Int Orthop (2007) 1.42
Tumor necrosis factor receptor cross-talk. FEBS J (2011) 1.40
Dendritic transport and localization of protein kinase Mzeta mRNA: implications for molecular memory consolidation. J Biol Chem (2004) 1.34
The effects of training and detraining on memory, neurotrophins and oxidative stress markers in rat brain. Neurochem Int (2006) 1.29
Glutamatergic (N-methyl-D-aspartate receptor) hypofrontality in schizophrenia: too little juice or a miswired brain? Mol Pharmacol (2009) 1.29
Exercise alters SIRT1, SIRT6, NAD and NAMPT levels in skeletal muscle of aged rats. Mech Ageing Dev (2009) 1.29
Physical exercise leads to rapid adaptations in hippocampal vasculature: temporal dynamics and relationship to cell proliferation and neurogenesis. Hippocampus (2009) 1.29
Experimental cerebral hypoperfusion induces white matter injury and microglial activation in the rat brain. Acta Neuropathol (2004) 1.24
Statins: mechanisms of neuroprotection. Prog Neurobiol (2009) 1.22
Generation and therapeutic efficacy of highly oligomer-specific beta-amyloid antibodies. J Neurosci (2010) 1.20
Chronically restricted sleep leads to depression-like changes in neurotransmitter receptor sensitivity and neuroendocrine stress reactivity in rats. Sleep (2008) 1.19
Metabolism and disposition of imatinib mesylate in healthy volunteers. Drug Metab Dispos (2005) 1.18
In vitro blood distribution and plasma protein binding of the tyrosine kinase inhibitor imatinib and its active metabolite, CGP74588, in rat, mouse, dog, monkey, healthy humans and patients with acute lymphatic leukaemia. Br J Clin Pharmacol (2004) 1.17
Phosphonic acid monolayers for binding of bioactive molecules to titanium surfaces. Langmuir (2006) 1.16
Transforming growth factor-beta-activated kinase-1 (TAK1), a MAP3K, interacts with Smad proteins and interferes with osteogenesis in murine mesenchymal progenitors. J Biol Chem (2005) 1.14
The dopamine D3 receptor plays an essential role in alcohol-seeking and relapse. FASEB J (2006) 1.12
Inflammation and NF-kappaB in Alzheimer's disease and diabetes. J Alzheimers Dis (2009) 1.11
Preservation of hippocampal neuron numbers in aged rhesus monkeys. Neurobiol Aging (2002) 1.10
Too little sleep gradually desensitizes the serotonin 1A receptor system. Sleep (2005) 1.07
Neuronal AKAP150 coordinates PKA and Epac-mediated PKB/Akt phosphorylation. Cell Signal (2008) 1.06
Maternal separation decreases adult hippocampal cell proliferation and impairs cognitive performance but has little effect on stress sensitivity and anxiety in adult Wistar rats. Behav Brain Res (2010) 1.05
Short-term administration of omega 3 fatty acids from fish oil results in increased transthyretin transcription in old rat hippocampus. Proc Natl Acad Sci U S A (2003) 1.05
Mesenchymal stem cell-dependent formation of heterotopic tendon-bone insertions (osteotendinous junctions). Stem Cells (2010) 1.03
Lipocalin 2: novel component of proinflammatory signaling in Alzheimer's disease. FASEB J (2012) 1.03
Renaturation and purification of bone morphogenetic protein-2 produced as inclusion bodies in high-cell-density cultures of recombinant Escherichia coli. J Biotechnol (2002) 1.02
mRNA expression of the murine glycoprotein (transmembrane) nmb (Gpnmb) gene is linked to the developing retinal pigment epithelium and iris. Brain Res Gene Expr Patterns (2002) 1.02
Habituation deficits induced by metabotropic glutamate receptors 2/3 receptor blockade in mice: reversal by antipsychotic drugs. J Pharmacol Exp Ther (2006) 1.02
TNF-alpha-mediates neuroprotection against glutamate-induced excitotoxicity via NF-kappaB-dependent up-regulation of K2.2 channels. J Neurochem (2008) 1.00
Wnt-ligand-dependent interaction of TAK1 (TGF-beta-activated kinase-1) with the receptor tyrosine kinase Ror2 modulates canonical Wnt-signalling. Cell Signal (2008) 1.00
Dexamethasone downregulates chemokine receptor CXCR4 and exerts neuroprotection against hypoxia/ischemia-induced brain injury in neonatal rats. Neuroimmunomodulation (2004) 0.99
Resveratrol preserves cerebrovascular density and cognitive function in aging mice. Front Aging Neurosci (2009) 0.98
Behavioral characterization of the mGlu group II/III receptor antagonist, LY-341495, in animal models of anxiety and depression. Eur J Pharmacol (2008) 0.98
In vivo RNAi-mediated silencing of TAK1 decreases inflammatory Th1 and Th17 cells through targeting of myeloid cells. Blood (2010) 0.98
Stimulation of the metabotropic glutamate 2/3 receptor attenuates social novelty discrimination deficits induced by neonatal phencyclidine treatment. Psychopharmacology (Berl) (2007) 0.97
Tendon and ligament engineering: from cell biology to in vivo application. Regen Med (2006) 0.95
Expression of galectin-3 in skeletal tissues is controlled by Runx2. J Biol Chem (2003) 0.95
Human bone marrow mesenchymal stem cells: a systematic reappraisal via the genostem experience. Stem Cell Rev (2011) 0.95
Amino-modified silica surfaces efficiently immobilize bone morphogenetic protein 2 (BMP2) for medical purposes. Acta Biomater (2010) 0.94
In silico study of full-length amyloid beta 1-42 tri- and penta-oligomers in solution. J Phys Chem B (2009) 0.94
Laser capture microdissection and microarray analysis of dividing neural progenitor cells from the adult rat hippocampus. Eur J Neurosci (2007) 0.94
KBP interacts with SCG10, linking Goldberg-Shprintzen syndrome to microtubule dynamics and neuronal differentiation. Hum Mol Genet (2010) 0.94
The effect of exercise and nettle supplementation on oxidative stress markers in the rat brain. Brain Res Bull (2005) 0.93
Age-related microvascular degeneration in the human cerebral periventricular white matter. Acta Neuropathol (2006) 0.93
Modification by docosahexaenoic acid of age-induced alterations in gene expression and molecular composition of rat brain phospholipids. Proc Natl Acad Sci U S A (2003) 0.93
Running wheel activity is sensitive to acute treatment with selective inhibitors for either serotonin or norepinephrine reuptake. Psychopharmacology (Berl) (2008) 0.93
Distinct roles of BMP receptors Type IA and IB in osteo-/chondrogenic differentiation in mesenchymal progenitors (C3H10T1/2). Biofactors (2004) 0.93
The T-box transcription factor Brachyury mediates cartilage development in mesenchymal stem cell line C3H10T1/2. J Cell Sci (2002) 0.93
A-kinase anchoring protein 150 in the mouse brain is concentrated in areas involved in learning and memory. Brain Res (2007) 0.92
The role of indoleamine 2,3-dioxygenase in a mouse model of neuroinflammation-induced depression. J Alzheimers Dis (2012) 0.92
Bone morphogenetic proteins promote cartilage differentiation and protect engineered artificial cartilage from fibroblast invasion and destruction. Arthritis Rheum (2002) 0.91
Differential involvement of hippocampal calcineurin during learning and reversal learning in a Y-maze task. Learn Mem (2006) 0.90
In vitro blood distribution and plasma protein binding of the iron chelator deferasirox (ICL670) and its iron complex Fe-[ICL670]2 for rat, marmoset, rabbit, mouse, dog, and human. Drug Metab Dispos (2006) 0.90
Morris water maze learning in two rat strains increases the expression of the polysialylated form of the neural cell adhesion molecule in the dentate gyrus but has no effect on hippocampal neurogenesis. Behav Neurosci (2005) 0.90
Neuroinflammation in Alzheimer's disease and major depression. Biol Psychiatry (2010) 0.90
Antibiotic and hemolytic activity of a beta2/beta3 peptide capable of folding into a 12/10-helical secondary structure. Chembiochem (2003) 0.89
The outstanding metabolic stability of a 14C-labeled beta-nonapeptide in rats--in vitro and in vivo pharmacokinetic studies. Biopharm Drug Dispos (2002) 0.89
Regular exercise: an effective means to reduce oxidative stress in old rats. Ann N Y Acad Sci (2004) 0.89
Transgenic inhibition of neuronal calcineurin activity in the forebrain facilitates fear conditioning, but inhibits the extinction of contextual fear memories. Neurobiol Learn Mem (2007) 0.89
Diazoxide and dimethyl sulphoxide prevent cerebral hypoperfusion-related learning dysfunction and brain damage after carotid artery occlusion. Brain Res (2004) 0.89
Effects of a positive allosteric modulator of group II metabotropic glutamate receptors, LY487379, on cognitive flexibility and impulsive-like responding in rats. J Pharmacol Exp Ther (2010) 0.89
SL651498, a GABAA receptor agonist with subtype-selective efficacy, as a potential treatment for generalized anxiety disorder and muscle spasms. CNS Drug Rev (2003) 0.89
Analysis of cognition, motor performance and anxiety in young and aged tumor necrosis factor alpha receptor 1 and 2 deficient mice. Behav Brain Res (2013) 0.88
Arterial blood pressure and renal sodium excretion in dopamine D3 receptor knockout mice. Hypertens Res (2007) 0.88
Effects of antipsychotics and selective D3 antagonists on PPI deficits induced by PD 128907 and apomorphine. Behav Brain Res (2007) 0.88
Inhibitors of GlyT1 affect glycine transport via discrete binding sites. Mol Pharmacol (2008) 0.88
Amphetamine decreases behavioral inhibition by stimulation of dopamine D2, but not D3, receptors. Behav Pharmacol (2009) 0.87
The basal forebrain cholinergic system in aging and dementia. Rescuing cholinergic neurons from neurotoxic amyloid-β42 with memantine. Behav Brain Res (2010) 0.87
Exchange protein activated by cyclic AMP 2 (Epac2) plays a specific and time-limited role in memory retrieval. Hippocampus (2010) 0.87
Differential effects of chronic partial sleep deprivation and stress on serotonin-1A and muscarinic acetylcholine receptor sensitivity. J Sleep Res (2006) 0.87
Development of disease-modifying treatment of schizophrenia. Handb Exp Pharmacol (2012) 0.86
Concentration dependent actions of glucocorticoids on neuronal viability and survival. Dose Response (2006) 0.86
Diazoxide and dimethyl sulphoxide alleviate experimental cerebral hypoperfusion-induced white matter injury in the rat brain. Neurosci Lett (2004) 0.85